Stockscreener 앱 받기
15.79
0.28%
-0.0469
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Hims & Hers to Acquire Eucalyptus in $1.15 Billion Deal - GuruFocus
M&A News: Hims & Hers (HIMS) Expands Globally with $1.15B Eucalyptus Buyout ahead of Q4 Earnings - TipRanks
Can Platform Strength Support Hims & Hers Stock Before Q4 Earnings? - Yahoo Finance Singapore
Hims & Hers Health Stock Resumes Climb on Acquisition News - Schaeffer's Investment Research
Hims & Hers Looks to Expand Globally With Buy of Australian Telehealth Provider - Barron's
Hims & Hers Health (HIMS) Rises on Eucalyptus Acquisition - GuruFocus
Hims plans to acquire Eucalyptus for up to $1.15B - Axios
Hims & Hers (HIMS) Stock: Company Acquires Eucalyptus for Up to $1.15 Billion - Blockonomi
What Is HIMS Worth Without GLP-1? Earnings Preview (NYSE:HIMS) - Seeking Alpha
4 stocks to watch on Thursday: HIMS, DPZ, WMT, PSX - Seeking Alpha
Why Is Hims & Hers Health Stock Trading Higher Today?Hims & Hers Health (NYSE:HIMS) - Benzinga
Hims & Hers under fire over copycat weight loss drugs - AOL.com
Hims & Hers to acquire Eucalyptus for up to $1.15 billion - Investing.com
Hims & Hers Health (HIMS) to Acquire Eucalyptus in $1.15 Billion Deal - GuruFocus
Hims & Hers is spending more than $1 billion in a push to expand globally - MarketWatch
Hims & Hers to acquire Australian digital health firm Eucalyptus, expanding international footprint - Proactive financial news
US FDA says Novo's obesity pill TV Ad is false or misleading - AOL.com
US Premarket Movers: Carvana, Deere, Hims & Hers, Walmart - Bloomberg.com
Hims & Hers Health to acquire Australia’s Eucalyptus for up to $1.15 billion - WKZO
Hims & Hers Stock Jumps on $1.15 Billion Deal to Acquire Australian Telehealth Provider - Barron's
Hims & Hers to Acquire Eucalyptus in Global Expansion - TipRanks
Hims & Hers Jumps Premarket After $1.15B Global Expansion Deal - Tokenist
Hims & Hers stock rises after agreement to acquire Eucalyptus By Investing.com - Investing.com Australia
Hims & Hers stock rises after agreement to acquire Eucalyptus - Investing.com UK
Hims & Hers to buy Australian digital health firm Eucalyptus for over $1B - Seeking Alpha
HIMS Acquires Eucalyptus in Deal Worth Up to $1.15 Billion - GuruFocus
Hims & Hers (HIMS) Plans Major Expansion with Eucalyptus Acquisi - GuruFocus
Hims & Hers Health Makes Australia, Japan Foray With $1.15 Billion Eucalyptus Acquisition - Stocktwits
Hims & Hers to Acquire Eucalyptus in Deal Valued Up to $1.15 Billion - TradingView
Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion - Reuters
Hims & Hers Health to Acquire Australia's Eucalyptus for up to $1.15 Billion - U.S. News & World Report
Hims & Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders - Reuters
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform - The Joplin Globe
How We’re Becoming the Leading Global Consumer Health Platform - Hims & Hers Newsroom
Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts - Yahoo Finance Singapore
Is Hims & Hers Health Inc Gaining or Losing Market Support? - Benzinga
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Hims And Hers Weighs Legal Risks Against Growth In Longevity Pivot - Yahoo Finance
Hims stock hits 52-week low at 15.62 USD - Investing.com India
Hims & Hers Health: 5 Key Questions Ahead Of Critical Q4 Earnings (NYSE:HIMS) - Seeking Alpha
Do You Think Hims & Hers Health (HIMS) is Positioned for Long-Term Growth? - Insider Monkey
Pre-Market: HIMS (Hims & Hers NYSE) $16.27 on 18 Feb 2026: earnings in focus - Meyka
Deutsche Bank Cite Near-Term Growth Concerns For Hims & Hers Health, Inc. (HIMS) Following GLP-1 Launch Reversal - Finviz
How Ozempic Brought a Napster Moment to Big Pharma - The Wall Street Journal
Market Whales and Their Recent Bets on HIMS Options - Benzinga
Novo Nordisk Patent Fight With Hims And Hers Puts Valuation In Focus - Yahoo Finance
Wall Street Sees 84% Upside in Hims & Hers (HIMS) Despite This Month’s 48% Selloff - 24/7 Wall St.
Analysts Estimate Hims & Hers Health, Inc. (HIMS) to Report a Decline in Earnings: What to Look Out for - Finviz
Hims & Hers Health Stock (HIMS) Opinions on Earnings Beat - Quiver Quantitative
Short Sellers Target Hims & Hers Amid Regulatory and Legal Challenges - AD HOC NEWS
Hims & Hers Health (HIMS) to Release Earnings on Monday - MarketBeat
Novo Nordisk sues Hims & Hers over ‘knock-off Wegovy’ - AOL.com
Hims & Hers is a brave bet on solving disrupter’s dilemma - Financial Times
Hims & Hers (HIMS) soars 16% on bullish analyst outlook - MSN
Hims & Hers Health, Inc. (NYSE:HIMS) Given Average Rating of "Hold" by Brokerages - MarketBeat
Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows - WHTC
Hims & Hers Health Inc (HIMS) Stock Price, Quote, News & History - Benzinga
Hims & Hers Health (HIMS) Is Down 29.2% After Semaglutide Lawsuit And DOJ ReferralHas The Bull Case Changed? - Yahoo Finance
Hims & Hers Health (HIMS) Faces Legal and Market Challenges - GuruFocus
Hims & Hers (HIMS) Faces High Short Interest Amid FDA Speculatio - GuruFocus
Hims and Hers Health (HIMS) Sees Bullish Options Activity with S - GuruFocus
0.59%
1.13%
자본화:
|
볼륨(24시간):